Archive: October 2015

PD-1/PD-L1 Immune Checkpoint Blockade in Non–Small Cell Lung Cancer

Stephen J. Bagley, MD, Joshua M. Bauml, MD, and Corey J. Langer, MD The authors are affiliated with the division of hematology/oncology at the Abramson Cancer […]

Adjuvant Endocrine Therapy in Premenopausal Women With Breast Cancer

Kunal C. Kadakia, MD, and N. Lynn Henry, MD, PhD The authors are affiliated with the University of Michigan Comprehensive Cancer Center. Dr Kadakia is a […]

Locoregional Therapy for Patients With Hepatocellular Carcinoma

Jean-Francois H. Geschwind, MD Professor of Radiology and Oncology Chairman, Department of Diagnostic Radiology Yale School of Medicine New Haven, Connecticut H&O  What are the most […]

Highlights in Kidney Cancer From the 2015 American Society of Clinical Oncology Annual Meeting

Highlights in Kidney Cancer From the 2015 American Society of Clinical Oncology Annual Meeting May 29-June 2, 2015 • Chicago, Illinois Biomarkers Associated With Improved Clinical […]

High-Dose Cytarabine in Mantle Cell Lymphoma

Peter Martin, MD Assistant Professor of Medicine Department of Hematology Weill Cornell Medical College Cornell University New York, New York H&O What are the current high-intensity […]

The Benefits and Drawbacks of Biosimilars

Bruce N. Cronstein, MD Professor of Medicine Department of Medicine Department of Biochemistry and Molecular Pharmacology Department of Pathology New York University School of Medicine New […]

What Should We Tell Our Patients With Colorectal Cancer About Diet, Supplements, and Lifestyle?

Jeffrey A. Meyerhardt, MD, MPH Associate Professor, Department of Medicine Harvard Medical School Clinical Director, Gastrointestinal Cancer Center Dana-Farber Cancer Institute Boston, Massachusetts H&O What would […]

Adjuvant Treatment For Patients With Surgically Resected Advanced-Stage Melanoma

Kenneth F. Grossmann, MD, PhD Assistant Professor Huntsman Cancer Institute University of Utah Salt Lake City, Utah H&O What is the first step in treating patients […]

October News

Devon Schuyler

Rolapitant Approved for Chemotherapy-Induced Nausea and Vomiting  The US Food and Drug Administration approved rolapitant (Varubi, Tesaro) on September 2 for chemotherapy-associated nausea and vomiting (CINV). […]

Letter From the Editor: Interviewing Season

Interviewing Season It is that time again: the interviewing season for prospective fellows. I think I should run a course for those writing letters of recommendation, […]

Back to Archive